The survival time of patients with Indolent cell carcinoma needs to be determined according to the patient’s physical condition, disease stage and treatment. Indolent cell carcinoma is a special type of mucus-secreting adenocarcinoma, commonly found in the gastrointestinal tract, breast, bladder and prostate areas, and rarely in the lung, which is not sensitive to chemotherapy and surgery is the preferred treatment. The survival time of patients with this disease is not fixed and is mainly related to the stage of the disease at the time of detection, the patient’s physical condition and treatment. In the early stage, the tumor is limited and can be treated by surgery in time, and the survival rate of 5 years after surgery can be more than 50% if the patient is in good health; in the middle stage, surgery with radiotherapy treatment, the survival rate of 5 years can also reach about 30%; in the late stage, the tumor has metastasized and the time for surgery is lost, so the patient can only take conservative treatment, and the survival time of the patient is relatively short, generally not more than 1 year. Patients need to pay attention to strengthen the intake of nutrition during the treatment period and carry out suitable physical exercise to enhance their own immunity, which can help prolong their life.